# Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics

> **NCT00773279** · PHASE3 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 242 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Delivery Systems

## Interventions

- **DEVICE:** FlexTouch®
- **DEVICE:** FlexPen®

## Key facts

- **NCT ID:** NCT00773279
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 242 (ACTUAL)
- **Last updated:** 2017-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00773279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00773279, "Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00773279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*